###begin article-title 0
###xml 53 54 47 48 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 105 108 <span type="species:ncbi:10116">rat</span>
PKCepsilon-dependent potentiation of TTX-resistant Nav1.8 current by neurokinin-1 receptor activation in rat dorsal root ganglion neurons
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Substance P (SP), which mainly exists in a subtype of small-diameter dorsal root ganglion (DRG) neurons, is an important signal molecule in pain processing in the spinal cord. Our previous results have proved the expression of SP receptor neurokinin-1 (NK-1) on DRG neurons and its interaction with transient receptor potential vanilloid 1 (TRPV1) receptor.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 71 72 71 72 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 220 221 220 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink">9</sup>
###xml 228 229 228 229 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 230 232 230 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink">11</sup>
###xml 284 285 284 285 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 127 130 <span type="species:ncbi:10116">rat</span>
In this study we investigated the effect of NK-1 receptor agonist on Nav1.8, a tetrodotoxin (TTX)-resistant sodium channel, in rat small-diameter DRG neurons employing whole-cell patch clamp recordings. NK-1 agonist [Sar9, Met(O2)11]-substance P (Sar-SP) significantly enhanced the Nav1.8 currents in a subgroup of small-diameter DRG neurons under both the normal and inflammatory situation, and the enhancement was blocked by NK-1 antagonist Win51708 and protein kinase C (PKC) inhibitor bisindolylmaleimide (BIM), but not the protein kinase A (PKA) inhibitor H89. In particular, the inhibitor of PKCepsilon, a PKC isoform, completely blocked this effect. Under current clamp model, Sar-SP reduced the amount of current required to evoke action potentials and increased the firing rate in a subgroup of DRG neurons.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 66 67 66 67 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
These data suggest that activation of NK-1 receptor potentiates Nav1.8 sodium current via PKCepsilon-dependent signaling pathway, probably participating in the generation of inflammatory hyperalgesia.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 296 297 296 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 298 299 298 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 552 553 552 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 554 555 554 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
Substance P (SP), a member of tachykinin family, is a well-known pain-related neuropeptide in the spinal cord. It is released by unmyelinated primary afferent fiber terminals of small-diameter dorsal root ganglion (DRG) neurons and participates in the spinal transmission of nociceptive signals [1-3]. It is well documented that the SP receptor neurokinin-1 (NK-1) is densely distributed in the superficial dorsal horn and involved in the development of chronic pain and central sensitization after intense noxious stimulation and tissue/nerve injury [4-7].
###end p 9
###begin p 10
###xml 313 314 313 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 350 351 350 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 536 538 536 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 539 541 539 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 579 580 579 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 344 348 <span type="species:ncbi:10116">rats</span>
In addition to the expression of the NK-1 on the postsynaptic neurons of superficial spinal dorsal horn, increasing evidence strongly suggested the presynaptic expression of NK-1 in DRG neurons. The immunohistochemical evidence revealed that the NK-1 was expressed by the unmyelinated axons of the glabrous skin [8], and the DRG neuron soma in rats [9]. By means of intracellular and whole-cell patch clamp recordings, SP was shown to be able to induce the depolarization of DRG or trigeminal ganglion neurons in the different species [10-13] and potentiated the TRPV1 currents [9]. However, the function of DRG-expressed NK-1 receptor needs to be further understood.
###end p 10
###begin p 11
###xml 6 7 6 7 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 107 109 107 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 189 191 189 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 203 204 203 204 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 223 224 223 224 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 340 342 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 388 389 388 389 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 473 475 473 475 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 479 480 479 480 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 543 545 543 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 546 548 546 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 213 217 <span type="species:ncbi:10090">mice</span>
###xml 238 242 <span type="species:ncbi:10090">mice</span>
The Nav1.8, which is a TTX-resistant sodium channel and mainly expressed in small-diameter DRG neurons [14,15], is a major contributor to the upstroke of action potential in these neurons [16]. In the Nav1.8-null mice or Nav1.8 knockdown mice by antisense oligodeoxynucleotides, both the physiological and pathological pain was alleviated [17-20]. Accumulative evidence showed that the Nav1.8 current was regulated by various inflammatory mediators, such as prostaglandin E2 (PGE2), serotonin, NGF etc. through a PKA or PKC signaling pathway [21-24]. 
###end p 11
###begin p 12
###xml 87 88 87 88 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 254 255 254 255 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
In the present study, we investigated the effects of the NK-1 agonist on dynamics of Nav1.8 currents in isolated small-diameter DRG neurons using whole-cell patch clamp recording. Also, the role of PKC signal pathway in the cross-talk between NK-1 and Nav1.8 was examined.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
###xml 15 16 15 16 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
Recording of Nav1.8 currents in DRG neurons
###end title 14
###begin p 15
###xml 298 299 297 298 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 337 338 336 337 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 343 345 342 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 346 348 345 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 367 368 366 367 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 505 507 504 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 570 572 569 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 605 606 604 605 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 653 655 652 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 686 688 685 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 776 777 775 776 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 880 881 879 880 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 977 979 976 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
With existence of TTX (500 nM) in external solution, TTX-resistant sodium currents were recorded in most (166 out of 205) of the small-diameter DRG neurons (<25 mum). The membrane potential was hold to -60 mV. Under this recording condition, TTX-resistant sodium currents were mainly mediated by Nav1.8 channels due to inactivation of Nav1.9 [25,26]. The family of Nav1.8 sodium currents was generated with a voltage-clamp protocol (depolarizing steps from -55 mV to 40 mV, 50 ms, 5 mV increments, Figure 1A). In accordance with the current-voltage relationship (Figure 1B), -10 mV was chosen to elicit Nav1.8 currents in most of the recordings (Figure 1C). As reported by Saab et al. [27], fluoride-based pipette solution also caused slow stabilization of the amplitude of Nav1.8 current after rupture of cell membrane in our experiments. We measured the peak amplitude of the Nav1.8 current at 5 min, 10 min and 15 min after whole-cell mode was performed. As shown in Figure 1D, the peak amplitude was relatively stable from 5 min to 15 min (n = 16). All of our subsequent recordings were performed in this time course.
###end p 15
###begin p 16
###xml 15 16 15 16 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 0 47 0 47 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Recording of Na<sub>v</sub>1.8 currents in rat DRG neurons</bold>
###xml 289 290 289 290 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 307 311 307 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I-V </italic>
###xml 322 323 322 323 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 380 381 380 381 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 496 497 496 497 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 32 35 <span type="species:ncbi:10116">rat</span>
Recording of Nav1.8 currents in rat DRG neurons. A: representative I-V curve family of currents recorded in the presence of 500 nM TTX is shown, using a protocol (inset) where cells were depolarized to a variety of potentials (-55 to +40 mV) from a holding potential of -60 mV to elicit Nav1.8 currents. B: I-V curve of Nav1.8 currents shown in (A). C: representative traces of Nav1.8 current elicited by a single pulse of -10 mV which was used in most of the recordings. D: peak amplitudes of Nav1.8 currents elicited by -10 mV pulse at 5 min, 10 min and 15 min after whole-cell mode was performed. The currents were stable during the recording time in all the cells (n = 16).
###end p 16
###begin title 17
###xml 32 33 32 33 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
Increase in peak amplitude of Nav1.8 current by Sar-SP
###end title 17
###begin p 18
###xml 80 81 79 80 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 152 157 151 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A, B</xref>
###xml 162 164 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 310 312 309 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 334 336 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 472 474 467 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 586 588 578 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 604 606 596 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 789 791 777 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D</xref>
Following the perfusion with Sar-SP (1 muM, 1 min), a selective NK-1 agonist, Nav1.8 currents were increased in 13 out of 30 DRG neurons tested (Figure 2A, B and 2C). The maximal enhancement of the peak amplitude occurred at 3 min after Sar-SP perfusion, and reduced slowly to control level thereafter (Figure 2A). As shown in Figure 2C, normalized currents were increased significantly by Sar-SP (116.2 +/- 2.9%, n = 13) compared with the control (99.2 +/- 0.5%, n = 16, p < 0.001). Higher concentration of Sar-SP (10 muM) failed to induce more powerful action (117.1 +/- 1.4%, n = 6, p < 0.001, Figure 2C), suggesting a "ceiling effect" at 1 muM. The Sar-SP-induced potentiation was blocked by co-incubation of Win51708, a selective NK-1 antagonist (5 muM, 98.5 +/- 0.6%, n = 15, Figure 2D). To exclude the influence of fluoride, we also test the effect of Sar-SP by using chloride-based pipette solution. Cesium fluoride was changed to cesium chloride. The effect of Sar-SP wasn't changed significantly (data not shown).
###end p 18
###begin p 19
###xml 35 36 35 36 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 0 48 0 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effect of NK-1 agonist Sar-SP on Na<sub>v</sub>1.8 currents</bold>
###xml 268 269 268 269 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 593 595 584 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 805 807 793 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 979 981 967 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 887 890 <span type="species:ncbi:31658">CFA</span>
###xml 962 965 <span type="species:ncbi:31658">CFA</span>
###xml 1025 1028 <span type="species:ncbi:31658">CFA</span>
Effect of NK-1 agonist Sar-SP on Nav1.8 currents. A: time course of the potentiation effect of Sar-SP. The maximal increase in the peak amplitude was at 3 min after Sar-SP perfusion, and reduced slowly to control level thereafter. B: typical traces illustrating the Nav1.8 current recorded in a neuron pre- (dashed line, control) and post- (solid line, Sar-SP) perfusion of 1 muM Sar-SP. C: histogram showing the effect of 1 muM and 10 muM Sar-SP. The normalized peak current was enhanced to 116.2 +/- 2.9% and 117.1 +/- 1.4% 3 min after perfusion of 1 muM and 10 muM Sar-SP, respectively (***p < 0.001, versus control, Kruskal-Wallis one-way ANOVA, n = 16 for control, 13 for 1 muM, and 6 for 10 muM). D: NK-1 antagonist Win51708 (5 muM) completely blocked the effect of Sar-SP in all 15 neurons tested (p > 0.05, t-test). E: The rate of the Sar-SP-responsive cells was increased after CFA-treatment. F: The effect of Sar-SP was also increased after peripheral CFA-treatment (* p < 0.05, t-test, n = 8 for saline and 14 for CFA-treated). G and H: Sar-SP shifted the activation (G) and steady-state inactivation (H) curve in a hyperpolarizing direction.
###end p 19
###begin p 20
###xml 26 27 26 27 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 242 243 241 242 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 416 417 414 415 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 437 439 435 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2E</xref>
###xml 481 482 479 480 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 664 666 658 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2F</xref>
###xml 668 670 662 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 738 739 732 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 126 129 <span type="species:ncbi:31658">CFA</span>
###xml 170 173 <span type="species:ncbi:10116">rat</span>
###xml 225 228 <span type="species:ncbi:31658">CFA</span>
###xml 352 356 <span type="species:ncbi:10116">rats</span>
###xml 445 449 <span type="species:ncbi:10116">rats</span>
###xml 455 458 <span type="species:ncbi:31658">CFA</span>
###xml 651 655 <span type="species:ncbi:10116">rats</span>
The effect of Sar-SP on Nav1.8 current was also examined under peripheral inflammation condition. Complete Freund's adjuvant (CFA, 100 mul) was bilaterally injected into rat hind paws. DRG neurons was tested three days after CFA treatment, Nav1.8 currents were enhanced by Sar-SP (1 muM) in 60.9% of DRG neurons (n = 23). In the saline treated control rats, 38.1% of DRG neurons (n = 21) exhibited potentiation of Nav1.8 current (Figure 2E). In rats with CFA treatment, the peak Nav1.8 current in DRG neurons was enhanced to 123.2 +/- 1.8% (n = 14) following application of Sar-SP, whereas enhanced to 117.4 +/- 1.5% (n = 8) in saline treated control rats (Figure 2F, p < 0.05). Given inflammation-induced increase in expression of NK-1 [9], it is suggested that such modulation of NK-1 may be more beneficial for controlling inflammatory chronic pain.
###end p 20
###begin title 21
###xml 72 73 72 73 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
Sar-SP shifted the activation and steady-state inactivation curves of Nav1.8 in a hyperpolarizing direction
###end title 21
###begin p 22
###xml 164 165 164 165 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 238 240 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2G</xref>
###xml 279 292 279 292 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1/2activation</sub>
###xml 412 414 408 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k </italic>
###xml 447 448 443 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 448 456 444 452 <sub xmlns:xlink="http://www.w3.org/1999/xlink">control </sub>
###xml 473 474 467 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 474 481 468 475 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Sar-SP </sub>
###xml 813 815 805 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2H</xref>
###xml 823 827 815 819 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1/2 </sub>
###xml 989 991 977 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k </italic>
###xml 1029 1030 1017 1018 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 1030 1038 1018 1026 <sub xmlns:xlink="http://www.w3.org/1999/xlink">control </sub>
###xml 1055 1056 1041 1042 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 1056 1063 1042 1049 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Sar-SP </sub>
As described above, a voltage-clamp protocol consisted of 50 ms depolarizing steps from -55 mV to 40 mV (5 mV increments) was used to determine the activation of Nav1.8 channels. Sar-SP caused a left shift of the activation curve (Figure 2G). Half-maximal activation potential (V1/2activation) was shifted to -20.03 +/- 0.23 mV from that of control condition (-14.24 +/- 0.25, n = 6) after Sar-SP perfusion. The k value was not changed by Sar-SP (kcontrol = 4.89 +/- 0.27, kSar-SP = 4.77 +/- 0.45). Steady-state inactivation was determined at a series of membrane potentials from -60 mV to 15 mV (5 mV increments) for 500 ms and a following test potential of 20 mV. Similar to the activation curve, the steady-state inactivation curve was also shifted in a hyperpolarized direction after Sar-SP perfusion (Figure 2H). The V1/2 of voltage dependence of steady-state inactivation was -19.31 +/- 0.23 mV (n = 6) using vehicle alone, and -25.55 +/- 0.14 mV after Sar-SP treatment (n = 6). The k value was also not changed by Sar-SP (kcontrol = 5.39 +/- 0.37, kSar-SP = 5.09 +/- 0.32).
###end p 22
###begin title 23
###xml 33 34 33 34 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
Sar-SP-induced potentiation of Nav1.8 via PKC, but not PKA
###end title 23
###begin p 24
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 154 155 154 155 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 167 169 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 297 298 297 298 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 433 434 432 433 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 518 519 517 518 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 531 533 530 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 538 540 537 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
Activation of NK-1, a G-protein coupled receptor, triggers several intracellular signal pathways, such as PKA and PKC pathway [28]. Given modulation of Nav1.8 by PKC [23,24,29], here we used bisindolylmaleimide (BIM), a PKC inhibitor, to examine its effect on the Sar-SP-induced potentiation of Nav1.8 currents. In all DRG neurons (n = 24) incubated with BIM (1 muM) for 30 min before Sar-SP perfusion, Sar-SP failed to potentiate Nav1.8 currents, suggesting a PKC-dependent mechanism in the interaction of NK-1 and Nav1.8 (Figure 3A and 3B).
###end p 24
###begin p 25
###xml 68 69 68 69 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 0 81 0 81 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Involvement of PKC, but not PKA in Sar-SP-induced potentiation of Na<sub>v</sub>1.8 currents</bold>
###xml 248 250 247 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 366 367 364 365 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 416 418 414 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
Involvement of PKC, but not PKA in Sar-SP-induced potentiation of Nav1.8 currents. Incubation with PKC inhibitor BIM (1 muM) for 30 min before Sar-SP perfusion completely blocked the potentiation effect of Sar-SP in all 24 neurons tested (A and B, p > 0.05, Mann-Whitney rank sum test). After incubation with PKA inhibitor H89, Sar-SP (1 muM) still fully enhanced Nav1.8 currents in 9 of 24 DRG neurons (C and D, ***p < 0.001, Mann-Whitney rank sum test).
###end p 25
###begin p 26
###xml 2 3 2 3 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 59 61 59 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 62 64 62 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 65 67 65 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 186 187 184 185 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 231 233 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 238 240 236 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3D</xref>
###xml 292 294 286 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 389 390 383 384 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
Nav1.8 currents were also reported to be regulated by PKA [22,23,30]. While the cells were incubated with the PKA inhibitor H89 (1 muM) for 30 min, Sar-SP (1 muM) still fully enhanced Nav1.8 currents in 9 of 24 DRG neurons (Figure 3C and 3D, control = 99.2 +/- 0.5%, Sar-SP = 115.6 +/- 2.1%, p < 0.001), suggesting that the PKA pathway did not participate in the interaction of NK-1 and Nav1.8.
###end p 26
###begin p 27
###xml 124 125 124 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 169 170 169 170 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 234 236 232 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 252 254 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 259 261 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 359 360 356 357 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 390 392 385 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 408 410 403 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 415 417 410 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 550 552 545 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 557 559 552 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4D</xref>
###xml 598 612 593 607 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1/2 activation</sub>
###xml 750 766 741 757 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1/2 inactivation</sub>
###xml 900 901 887 888 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 991 993 978 980 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k </italic>
###xml 1054 1055 1041 1042 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 1055 1063 1042 1050 <sub xmlns:xlink="http://www.w3.org/1999/xlink">control </sub>
###xml 1080 1081 1065 1066 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 1081 1085 1066 1070 <sub xmlns:xlink="http://www.w3.org/1999/xlink">PMA </sub>
###xml 1116 1117 1099 1100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 1117 1125 1100 1108 <sub xmlns:xlink="http://www.w3.org/1999/xlink">control </sub>
###xml 1142 1143 1123 1124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 1143 1147 1124 1128 <sub xmlns:xlink="http://www.w3.org/1999/xlink">PMA </sub>
Further, PMA (phorbol 12-myristate 13-acetate), a PKC activator, was used to mimic the effect of Sar-SP. As shown in Figure 4, PMA (300 nM) significantly enhanced the Nav1.8 currents by 19.5 +/- 3.2% in 10 out of 13 recorded neurons (p < 0.001, Figure 4A and 4B). Notably, perfusion with Sar-SP (1 muM) failed to further enhance PMA-induced potentiation of Nav1.8 currents (118.3 +/- 2.2%, p < 0.001, Figure 4A and 4B). After PMA perfusion, the activation and steady-state inactivation curves were also shifted in a hyperpolarizing direction (Figure 4C and 4D). Half-maximal activation potential (V1/2 activation) was shifted to -18.97 +/- 0.28 mV from that of control condition (-14.37 +/- 0.18 mV, n = 6). The half-maximal inactivation potential (V1/2 inactivation) was shifted to -24.48 +/- 0.10 mV from -19.41 +/- 0.18 mV (control, n = 6). These results further confirmed that Sar-SP modulated Nav1.8 channels in a PKC-dependent pathway. In consistent with Sar-SP, PMA didn't change the k value in the activation and inactivation curves (activation: kcontrol = 4.59 +/- 0.26, kPMA = 4.64 +/- 0.68; inactivation: kcontrol = 5.39 +/- 0.37, kPMA = 5.14 +/- 0.36).
###end p 27
###begin p 28
###xml 0 30 0 30 <bold xmlns:xlink="http://www.w3.org/1999/xlink">PMA mimic the effect of Sar-SP</bold>
###xml 115 116 115 116 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 290 292 289 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 471 472 470 471 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
PMA mimic the effect of Sar-SP. A and B:representative traces (A) and histogram (B) showing the effect of PMA on Nav1.8 currents. 300 nM PMA induced a similar potentiation to 1 muM Sar-SP. Perfusion with Sar-SP failed to further enhance the currents after PMA-induced peak potentiation (***p < 0.001, versus control, Kruskal-Wallis one-way ANOVA, n = 16 for control, 10 for PMA and 10 for Sar-SP). PMA also shifted the activation and steady-state inactivation curve of Nav1.8 in a hyperpolarized direction (C and D).
###end p 28
###begin title 29
###xml 51 52 45 46 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
PKCepsilon: a pivotal factor for potentiation of Nav1.8 by NK-1 activation
###end title 29
###begin p 30
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 257 258 251 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 259 261 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 262 264 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 350 351 338 339 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 490 491 465 466 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 617 619 586 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 624 626 593 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
As reported, there are five isoforms of PKC expressed in DRG neurons [31]. Among these isoforms, PKCepsilon is highly expressed in small-diameter DRG neurons and involved in NK-1 activation-induced potentiation of TRPV1 and the development of hyperalgesia [9,31-33]. Therefore, to explore the effect of PKCepsilon on Sar-SP-induced potentiation of Nav1.8, epsilonV1-2 (200 muM), a specific PKCepsilon inhibitor, was delivered intracellularly via recording electrodes. The potentiation of Nav1.8 currents was completely blocked by epsilonV1-2 (n = 15), but not by its negative control (control peptide) (n = 8, Figure 5A and 5B).
###end p 30
###begin p 31
###xml 0 66 0 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink">PKC&#949; was the main PKC subtype mediating the effect of Sar-SP</bold>
###xml 417 419 386 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
PKCepsilon was the main PKC subtype mediating the effect of Sar-SP. A and B: representative traces (A) and histogram (B) showing the effect of PKCepsilon inhibitor epsilonV1-2 on Sar-SP-induced potentiation. Intracellular application of epsilonV1-2 (200 muM) completely abolished the potentiation effect of Sar-SP. The negative control (control peptide) of epsilonV1-2 failed to block Sar-SP-induced potentiation (***p < 0.001, versus normal control, one-way ANOVA, n = 16 for normal control, 11 for epsilonV1-2 and 8 for negative control).
###end p 31
###begin title 32
Effect of Sar-SP on excitability of DRG neuron
###end title 32
###begin p 33
###xml 2 3 2 3 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 99 101 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 430 432 430 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 437 439 437 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 712 714 708 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6C</xref>
###xml 723 725 719 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
Nav1.8 is the main contributor to the upstroke of action potentials in small-diameter DRG neurons [16]. Therefore, modulation of this channel by Sar-SP should influence excitability of the DRG neuron. We detected the effect of Sar-SP on the threshold for evoking action potential in DRG neurons. To evoke action potentials, 5 ms step depolarizing current pulses were applied to neurons before and after exposure to Sar-SP (Figure 6A and 6B). In 6 of 17 neurons tested, Sar-SP significantly decreased the injected current threshold to evoke action potentials. Under the control condition, the current threshold was 116.7 +/- 7.6 pA. After exposure to Sar-SP, this threshold was reduced to 80.0 +/- 5.2 pA (Figure 6C, n = 6, p < 0.01).
###end p 33
###begin p 34
###xml 0 83 0 82 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effect of 1 &#956;M Sar-SP on action potential threshold and firing rate in DRG neurons</bold>
###xml 545 547 544 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 770 772 769 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
Effect of 1 muM Sar-SP on action potential threshold and firing rate in DRG neurons. Sar-SP reduced the amount of current required to evoke action potential and increased the firing rate in DRG neurons. Experiments were performed using current clamp model. A and B: depolarizing current pulse required to evoke an action potential in a DRG neuron, before (A) and after (B) application of Sar-SP (a = 130 pA, b = 140 pA, c = 80 pA, d = 90 pA). C: effect of Sar-SP on the threshold for action potential generation by depolarizing current pulse (**p < 0.01, paired t-test, n = 6). D and E: firing response of a DRG neuron to a 500 pA depolarizing current pulse (500 ms), before (D) and after (E) application of Sar-SP. F: effect of Sar-SP on firing rate in DRG neurons (***p < 0.001, paired t-test, n = 6).
###end p 34
###begin p 35
###xml 156 158 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6D</xref>
###xml 163 165 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6F</xref>
###xml 256 258 252 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6E</xref>
###xml 263 265 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6F</xref>
###xml 274 276 270 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
In addition, during injection of supramaximal depolarizing current pulses (500 ms, 500 pA), DRG neurons fired with a frequency at 21.22 +/- 1.57 Hz (Figure 6D and 6F, n = 6). Sar-SP significantly increased the firing frequency to 33.22 +/- 1.53 Hz (Figure 6E and 6F, n = 6, p < 0.001).
###end p 35
###begin title 36
Discussion
###end title 36
###begin p 37
###xml 466 468 466 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 469 471 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 472 474 472 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 475 477 475 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 518 520 518 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 682 683 682 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
The role of substance P (SP) and its NK-1 receptor in pain processing was widely investigated in the spinal cord. However, most of the prevailing studies focused on the postsynaptic NK-1 receptors in the spinal superficial dorsal horn neurons. Whether NK-1 receptors are also expressed presynaptically in primary sensory neurons is still obscure. A growing body of evidence showed that SP could activate DRG neurons through NK-1 receptor in primary sensory neurons [10-13,34,35], in despite of a contradictory report [36]. Our recent study provided new evidence for the expression of NK-1 receptor protein and interaction with TRPV1, a crucial pain signal molecule, in DRG neurons [9].
###end p 37
###begin p 38
###xml 192 193 192 193 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 203 204 203 204 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 211 212 211 212 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 325 326 325 326 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 529 531 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 563 564 563 564 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 683 685 683 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 686 688 686 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 689 691 689 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 692 694 692 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 749 750 749 750 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 843 845 843 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 846 848 846 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 932 933 932 933 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 1103 1104 1103 1104 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 1279 1280 1279 1280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 1497 1498 1497 1498 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 1634 1635 1634 1635 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 1727 1729 1727 1729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 1806 1808 1806 1808 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 1809 1811 1809 1811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1812 1814 1812 1814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 1815 1817 1815 1817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 1863 1864 1863 1864 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 335 339 <span type="species:ncbi:10090">mice</span>
In addition to TRPV1, another important ion channel, TTX-resistant sodium channel, is also primarily expressed in nociceptors. Between the two distinct TTX-resistant sodium channel isoforms Nav1.8 and Nav1.9, Nav1.8 likely mediates the majority of the TTX-resistant currents and plays an important role in pain processing. Nav1.8-null mice displayed a pronounced increase in threshold to noxious mechanical stimuli and a slight decrease in nociceptive thermoreception as well as delayed development of inflammatory hyperalgesia [17]. Likewise, knocking-down of Nav1.8 mRNA with antisense oligodeoxynucleotides was effective in alleviating both the inflammatory and neuropathic pain [18-20,37,38]. Also, muO-conotoxin MrVIB, a selective blocker of Nav1.8, reduced allodynia and hyperalgesia in neuropathic and chronic inflammatory pain models [39,40]. The present study for the first time revealed that NK-1 activation potentiated Nav1.8 currents and shifted both the activation and steady-state inactivation curves of this channel in a hyperpolarizing direction. This change in voltage sensitivity of Nav1.8 may decrease the activate threshold and increase the likelihood of action potential firing, and then probably cause a hyperexcitability of the neurons. As shown in Figure 6, the enhancement of excitability was observed in our experiments. Although the involvement of Sar-SP-induced modulation on other ion channels still need to be further investigated, it is assumed that modulation on Nav1.8 at least partly contributes to this enhancement of excitability. Similar results were also obtained from studies on modulation of Nav1.8 by another peripheral pain-related neuropeptide calcitonin gene related peptide (CGRP) [41] and proinflammatory factors such as 5-hydroxytryptamine and prostaglandin E2 [22,42,43]. It is conceivable that the modulation of Nav1.8 by NK-1 activation may contribute to peripheral sensitization of pain pathway.
###end p 38
###begin p 39
###xml 47 49 47 49 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 396 397 396 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 493 494 493 494 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 518 519 518 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 531 532 531 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 604 605 604 605 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 684 685 684 685 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 743 744 743 744 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 835 836 835 836 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 856 858 856 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 859 861 859 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 862 864 862 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 1127 1129 1127 1129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1178 1194 1178 1194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus oocytes </italic>
###xml 1254 1255 1254 1255 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 1310 1312 1310 1312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1035 1038 <span type="species:ncbi:10116">rat</span>
###xml 1178 1185 <span type="species:ncbi:8355">Xenopus</span>
NK-1 receptor is a G-protein coupled receptor [28]. The activation of NK-1 receptors generates various second messengers, which, in turn, trigger a wide range of effector mechanisms underlying regulating cellular excitability and functions [44-47]. In agreement with our previous finding that the modulation of TRPV1 by NK-1 receptor was mediated by activation of PLC and downstream PKC pathway [9], the present results also proved the involvement of PKC in the interaction between NK-1 and Nav1.8. As shown in Figure 3 and Figure 4, PKC inhibitor BIM completely blocked Sar-SP-induced potentiation of Nav1.8 currents, whereas PKC activator PMA could mimic the effects of Sar-SP on Nav1.8 currents. These results suggest that NK-1 modulates Nav1.8 in a PKC-dependent pathway. There are many other papers confirmed the enhancement of Nav1.8 by PKC pathway [24,48,49]. However, the inconsistent results have been reported. Gold et al. reported that PKC activation also caused an increase in the amplitude of the TTX-resistant current in rat DRG neurons. But this increase was not associated with a shift in the activation curve [23]. Vijayaragavan and colleagues reported that in Xenopus oocytes expression system, PKC activator PMA caused a decrease of Nav1.8 current and a right shift of the activation curve [29]. The reason for the difference is still unclear.
###end p 39
###begin p 40
###xml 115 116 103 104 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 254 255 236 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
Furthermore, we observed that PKCepsilon inhibitor epsilonV1-2 completely blocked Sar-SP-induced potentiation of Nav1.8 currents, suggesting that PKCepsilon was the main mediator of NK-1 potentiation, in consistence with the modulation of TRPV1 by NK-1 [9].
###end p 40
###begin p 41
###xml 160 161 160 161 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 167 169 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 253 254 253 254 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 346 347 346 347 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
In addition to the PKC pathway, several reports showed that PKA was also involved in the increase of TTX-resistant currents by proinflammatory agents (5-HT, PGE2) [22,23,42]. However, PKA inhibitor H89 failed to prevent Sar-SP-induced potentiation of Nav1.8 in the present study. These suggested the diverse mechanisms underlying modulation of Nav1.8 by the different proinflammatory agents. Therefore, the modulatory action of NK-1 may be predominately mediated by PKC, particularly by PKCepsilon, but not PKA.
###end p 41
###begin p 42
###xml 53 54 53 54 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 110 112 110 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 113 115 113 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 273 274 267 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 275 277 269 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 326 327 320 321 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 509 510 497 498 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 669 670 657 658 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 247 250 <span type="species:ncbi:31658">CFA</span>
###xml 611 614 <span type="species:ncbi:31658">CFA</span>
It is well documented an increase in expression of Nav1.8 in DRG neurons in several inflammatory pain models [50-53]. Our previous results have revealed that both the NK-1 expression and phosphorylation of PKCepsilon are up-regulated in DRG after CFA-induced inflammation [9,33]. Therefore, we assume that the modulation of Nav1.8 by NK-1 via PKCepsilon is likely to be stronger after peripheral inflammation. In support of this view, the present study showed that not only the effect of NK-1 activation on Nav1.8 currents was significantly potentiated, but also the rate of Sar-SP-responsive neurons following CFA treatment. It is conceivable that the modulation of Nav1.8 by NK-1 may amplify peripheral nociceptive inputs and in turn strengthen activation of the pain-sensitive neurons in the spinal cord, contributing to inflammatory pain.
###end p 42
###begin title 43
Conclusion
###end title 43
###begin p 44
###xml 66 67 66 67 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 299 300 299 300 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 216 219 <span type="species:ncbi:10116">rat</span>
Substance P (SP) receptor NK-1 and TTX-resistant sodium channel Nav1.8 expressed on nociceptors are two important molecules for pain processing. The present study for the first time investigated their interaction in rat DRG neurons. The results showed that activation of NK-1 receptor potentiates Nav1.8 sodium current via PKCepsilon-dependent signaling pathway, probably participating in the generation of inflammatory hyperalgesia.
###end p 44
###begin title 45
Methods
###end title 45
###begin title 46
Animals
###end title 46
###begin p 47
###xml 282 292 274 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ad libitum</italic>
###xml 23 42 <span type="species:ncbi:10116">Sprague-Dawley rats</span>
###xml 173 177 <span type="species:ncbi:10116">Rats</span>
Male adult (100-150 g) Sprague-Dawley rats (obtained from the Experimental Animal Center, Shanghai Medical College of Fudan University, China) were used in our experiments. Rats were on a 12 h light/dark cycle with a room temperature of 22 +/- 1degreesC and received food and water ad libitum. All experimental procedures were approved by the Shanghai Animal Care and Use Committee and followed the policies issued by the International Association for the Study of Pain on the use of laboratory animals. All efforts were made to minimize animal suffering and reduce the numbers of animals used.
###end p 47
###begin title 48
Cell preparation
###end title 48
###begin p 49
###xml 64 66 64 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 89 90 89 90 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 92 94 92 94 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6 </sub>
###xml 550 551 544 545 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 559 560 553 554 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
Culture of DRG neurons was established as described previously [33]. Briefly, DRGs from L4-L6 lumbar segments were dissected and incubated at 36.8degreesC for 25 min in DMEM containing 3 mg/ml collagenase (type IA, Sigma, St. Louis, MO) and, 1 mg/ml trypsin (type I, Sigma). The ganglias were then gently triturated using fine fired-polished Pasteur pipettes. The dissociated DRG neurons were plated onto coverslips (10 mm diameter) in the 3.5 cm culture dishes and incubated with Standard external solution containing (in mM) 150 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES, and 10 glucose, adjusted to pH 7.4 with NaOH.
###end p 49
###begin title 50
Patch-clamp recordings
###end title 50
###begin p 51
###xml 883 884 872 873 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 900 901 889 890 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 968 969 957 958 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 1066 1067 1055 1056 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1075 1076 1064 1065 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1086 1087 1075 1076 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1172 1173 1161 1162 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1211 1212 1200 1201 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1216 1218 1205 1207 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1352 1353 1341 1342 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1363 1364 1352 1353 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1390 1391 1379 1380 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1492 1493 1481 1482 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1501 1502 1490 1491 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
Whole-cell voltage-clamp and current-clamp recordings of DRG neurons were performed at room temperature (20-22degreesC) with an EPC-9 amplifier (HEKA Elektronik, Lambrecht/Pfalz, Germany). Stimulation protocols and data acquisition were controlled by the software Pulse and Pulsefit 8.5 (HEKA Elektronik). Neurons were prepared as above, and all recordings were performed within 2-8 h after plating. All of the recordings were made from small-diameter (15-25 mum) DRG neurons. After gigaohm seal formation and membrane disruption, the whole cell capacitance was cancelled and series resistance was compensated (> 80%). Microelectrodes were fabricated from 1.5 mm out diameter borosilicate capillary glass (Sutter Instruments, Novato, CA) by using a P-97 puller (Sutter Instruments, Novato, CA), and had a resistance of 3-5 MOmega. Electrodes were filled with (in mM): 140 CsF, 1 MgCl2, 1 EGTA, 2.5 Na2ATP, 10 HEPES, pH was adjusted to 7.2 with CsOH. In recording of Nav1.8 currents, the external solution contained (in mM): 32 NaCl, 20 TEA-Cl, 105 choline-Cl, 1 MgCl2, 1 CaCl2, 0.1 CdCl2, 10 HEPES, 0.0005 TTX and 10 glucose, adjusted to pH 7.4 with NaOH. The TEA-Cl, CdCl2, TTX was used to inhibit endogenous K+, Ca2+, and TTX-sensitive sodium currents, respectively. In current-clamp recordings, the electrode solution was changed to: 140 KCl, 1 MgCl2, 0.5 CaCl2, 5 EGTA, 10 HEPES, 2.5 Na2ATP, pH was adjusted to 7.2 with KOH. The external solution was changed to: 150 NaCl, 5 KCl, 2.5 CaCl2, 1 MgCl2, 10 HEPES, pH was adjusted to 7.4 with NaOH.
###end p 51
###begin title 52
Drugs
###end title 52
###begin p 53
###xml 334 335 316 317 <sup xmlns:xlink="http://www.w3.org/1999/xlink">9</sup>
###xml 342 343 324 325 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 344 346 326 328 <sup xmlns:xlink="http://www.w3.org/1999/xlink">11</sup>
All the drugs were purchased from Sigma (St. Louis, MO, USA), except that the PKCepsilon inhibitor epsilonV1-2 and its negative control were from Biomol (Plymouth Meeting, PA). All the drugs are prepared on the day of the experiment from stocks kept at -20degreesC at a concentration at least 1000-fold the working concentration. [Sar9, Met(O2)11]-substance P (Sar-SP) and PMA were applied close to the cells through a ALA-VM8 perfusion system (ALA Scientific Instruments, Westbury, NY). Inhibitors were applied (where appropriate) to the chamber for 30 min before the perfusion of Sar-SP and PMA and existed during the whole recording course.
###end p 53
###begin title 54
Data analysis
###end title 54
###begin p 55
###xml 83 86 83 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink"> G </italic>
###xml 88 89 88 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 91 92 91 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 92 94 92 94 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m </sub>
###xml 96 97 96 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 97 99 97 99 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Na</sub>
###xml 108 110 108 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G </italic>
###xml 130 132 130 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I </italic>
###xml 163 164 163 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 164 166 164 166 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m </sub>
###xml 197 198 197 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 198 201 198 201 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Na </sub>
###xml 242 243 242 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 339 342 339 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G/G</italic>
###xml 342 346 342 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">max </italic>
###xml 342 346 342 346 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>max </italic></sub>
###xml 355 359 355 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">exp </italic>
###xml 361 362 361 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 362 366 362 366 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1/2 </sub>
###xml 368 369 368 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 369 370 369 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">m</italic>
###xml 369 370 369 370 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>m</italic></sub>
###xml 372 373 372 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 383 384 383 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 384 388 384 388 <sub xmlns:xlink="http://www.w3.org/1999/xlink">max </sub>
###xml 413 414 413 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 414 418 414 418 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1/2 </sub>
###xml 467 469 467 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k </italic>
###xml 579 580 579 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 581 582 581 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 582 586 582 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">max </italic>
###xml 582 586 582 586 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>max </italic></sub>
###xml 595 599 595 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">exp </italic>
###xml 601 602 601 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 603 604 603 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 604 607 604 607 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1/2</sub>
###xml 609 610 609 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 620 621 620 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 621 625 621 625 <sub xmlns:xlink="http://www.w3.org/1999/xlink">max </sub>
###xml 654 656 654 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V </italic>
###xml 692 693 692 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 693 697 693 697 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1/2 </sub>
###xml 746 748 746 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k </italic>
Peak sodium current values were converted to conductance values using the equation: G = I/(Vm - ENa), where G is the conductance, I is the peak current amplitude, Vm is the membrane potential, and ENa is the equilibrium potential value for Na+. The Boltzmann equation used to describe the voltage dependence of activation was of the form: G/Gmax = 1/(1 + exp [(V1/2 - Vm)/k]), where Gmax is the peak conductance, V1/2 is the potential at half maximal activation, and k is the slope factor. Voltage dependence of steady-state inactivation was described by the Boltzmann function: I/Imax = 1/(1 + exp [(V-V1/2)/k]), where Imax is the maximal peak current, V is the prepulse membrane potential, V1/2 is the potential at half maximal activation, and k is the slope factor.
###end p 55
###begin p 56
###xml 357 359 355 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Data are expressed as means +/- standard error of the mean (SEM). Statistical analysis was performed using SigmaStat software (Systat Software, Chicago, IL). Student's t-test or Mann-Whitney analysis was used to assess differences between means from two groups. One-way ANOVA or Kruskal-Wallis one-way ANOVA was used to assess difference among more groups. P < 0.05 was considered significant. Curves were plotted and fitted using Origin software (OriginLab Corporation, Northampton, USA).
###end p 56
###begin title 57
Abbreviations
###end title 57
###begin p 58
###xml 144 145 144 145 <sup xmlns:xlink="http://www.w3.org/1999/xlink">9</sup>
###xml 152 153 152 153 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 154 156 154 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink">11</sup>
###xml 246 247 246 247 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 264 265 264 265 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 305 308 <span type="species:ncbi:31658">CFA</span>
SP: Substance P; DRG: dorsal root ganglion; NK-1: neurokinin-1; TRPV1: transient receptor potential vanilloid 1; TTX: tetrodotoxin; Sar-SP: [Sar9, Met(O2)11]-substance P; PKC: protein kinase C; BIM: bisindolylmaleimide; PKA: protein kinase A; PGE2: prostaglandin E2; PMA: phorbol 12-myristate 13-acetate; CFA: complete Freund's adjuvant.
###end p 58
###begin title 59
Competing interests
###end title 59
###begin p 60
The authors declare that they have no competing interests.
###end p 60
###begin title 61
Authors' contributions
###end title 61
###begin p 62
CLC and HZ performed the patch clamp recordings in DRG neurons. YQZ was partially involved in experimental design and guiding. ZQZ is the corresponding author.
###end p 62
###begin title 63
Acknowledgements
###end title 63
###begin p 64
This work was supported by grant from the National Basic Research Program of China Grant 2006CB500807 and the National Natural Science Fund of China 30600178.
###end p 64
###begin article-title 65
Primary afferent tachykinins are required to experience moderate to intense pain
###end article-title 65
###begin article-title 66
The tachykinin NK1 receptor. Part II: Distribution and pathophysiological roles
###end article-title 66
###begin article-title 67
Null mutations lacking substance: elucidating pain mechanisms by genetic pharmacology
###end article-title 67
###begin article-title 68
Tachykinins: receptor to effector
###end article-title 68
###begin article-title 69
Inhibition of hyperalgesia by ablation of lamina I spinal neurons expressing the substance P receptor
###end article-title 69
###begin article-title 70
Transmission of chronic nociception by spinal neurons expressing the substance P receptor
###end article-title 70
###begin article-title 71
Superficial NK1-expressing neurons control spinal excitability through activation of descending pathways
###end article-title 71
###begin article-title 72
###xml 64 67 <span type="species:ncbi:10116">rat</span>
Inflammation-induced up-regulation of neurokinin 1 receptors in rat glabrous skin
###end article-title 72
###begin article-title 73
Neurokinin-1 receptor enhances TRPV1 activity in primary sensory neurons via PKCepsilon: a novel pathway for heat hyperalgesia
###end article-title 73
###begin article-title 74
###xml 58 66 <span type="species:ncbi:8400">bullfrog</span>
Tachykinins cause inward current through NK1 receptors in bullfrog sensory neurons
###end article-title 74
###begin article-title 75
###xml 32 35 <span type="species:ncbi:10116">rat</span>
Effects of substance P on adult rat sensory ganglion neurones in vitro
###end article-title 75
###begin article-title 76
###xml 66 69 <span type="species:ncbi:10116">rat</span>
Nonselective cation channels coupled with tachykinin receptors in rat sensory neurons
###end article-title 76
###begin article-title 77
###xml 29 32 <span type="species:ncbi:10116">rat</span>
Small sensory neurons in the rat dorsal root ganglia express functional NK-1 tachykinin receptor
###end article-title 77
###begin article-title 78
A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons
###end article-title 78
###begin article-title 79
###xml 106 109 <span type="species:ncbi:10116">rat</span>
The TTX-resistant sodium channel Nav1.8 (SNS/PN3): expression and correlation with membrane properties in rat nociceptive primary afferent neurons
###end article-title 79
###begin article-title 80
Contribution of Na(v)1.8 sodium channels to action potential electrogenesis in DRG neurons
###end article-title 80
###begin article-title 81
The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways
###end article-title 81
###begin article-title 82
Involvement of the TTX-resistant sodium channel Nav 1.8 in inflammatory and neuropathic, but not post-operative, pain states
###end article-title 82
###begin article-title 83
###xml 74 77 <span type="species:ncbi:10116">rat</span>
A tetrodotoxin-resistant sodium current mediates inflammatory pain in the rat
###end article-title 83
###begin article-title 84
Inhibition of neuropathic pain by decreased expression of the tetrodotoxin-resistant sodium channel, NaV1.8
###end article-title 84
###begin article-title 85
The role of sodium channels in chronic inflammatory and neuropathic pain
###end article-title 85
###begin article-title 86
###xml 69 72 <span type="species:ncbi:10116">rat</span>
PGE2 modulates the tetrodotoxin-resistant sodium current in neonatal rat dorsal root ganglion neurones via the cyclic AMP-protein kinase A cascade
###end article-title 86
###begin article-title 87
###xml 87 90 <span type="species:ncbi:10116">rat</span>
Modulation of TTX-R INa by PKC and PKA and their role in PGE2-induced sensitization of rat sensory neurons in vitro
###end article-title 87
###begin article-title 88
###xml 61 64 <span type="species:ncbi:10116">rat</span>
The effect of PKC activity on the TTX-R sodium currents from rat nodose ganglion neurons
###end article-title 88
###begin article-title 89
A novel persistent tetrodotoxin-resistant sodium current in SNS-null and wild-type small primary sensory neurons
###end article-title 89
###begin article-title 90
Contactin regulates the current density and axonal expression of tetrodotoxin-resistant but not tetrodotoxin-sensitive sodium channels in DRG neurons
###end article-title 90
###begin article-title 91
GTP gamma S increases Nav1.8 current in small-diameter dorsal root ganglia neurons
###end article-title 91
###begin article-title 92
The tachykinin NK1 receptor. Part I: ligands and mechanisms of cellular activation
###end article-title 92
###begin article-title 93
Modulation of Nav1.7 and Nav1.8 peripheral nerve sodium channels by protein kinase A and protein kinase C
###end article-title 93
###begin article-title 94
cAMP-dependent phosphorylation of the tetrodotoxin-resistant voltage-dependent sodium channel SNS
###end article-title 94
###begin article-title 95
Specific involvement of PKC-epsilon in sensitization of the neuronal response to painful heat
###end article-title 95
###begin article-title 96
###xml 81 85 <span type="species:ncbi:10090">mice</span>
A novel nociceptor signaling pathway revealed in protein kinase C epsilon mutant mice
###end article-title 96
###begin article-title 97
###xml 80 83 <span type="species:ncbi:10116">rat</span>
State-dependent phosphorylation of epsilon-isozyme of protein kinase C in adult rat dorsal root ganglia after inflammation and nerve injury
###end article-title 97
###begin article-title 98
###xml 73 78 <span type="species:ncbi:10090">mouse</span>
Expression of tachykinin NK1 receptor mRNA in dorsal root ganglia of the mouse
###end article-title 98
###begin article-title 99
###xml 74 78 <span type="species:ncbi:10116">rats</span>
Neurokinin-1 receptor expression in dorsal root ganglion neurons of young rats
###end article-title 99
###begin article-title 100
Central and peripheral expression of neurokinin-1 and neurokinin-3 receptor and substance P-encoding messenger RNAs: peripheral regulation during formalin-induced inflammation and lack of neurokinin receptor expression in primary afferent sensory neurons
###end article-title 100
###begin article-title 101
###xml 146 150 <span type="species:ncbi:10116">rats</span>
Small interfering RNA-mediated selective knockdown of Na(V)1.8 tetrodotoxin-resistant sodium channel reverses mechanical allodynia in neuropathic rats
###end article-title 101
###begin article-title 102
###xml 130 134 <span type="species:ncbi:10090">mice</span>
The tetrodotoxin-resistant Na+ channel Nav1.8 is essential for the expression of spontaneous activity in damaged sensory axons of mice
###end article-title 102
###begin article-title 103
Synthetic muO-conotoxin MrVIB blocks TTX-resistant sodium channel NaV1.8 and has a long-lasting analgesic activity
###end article-title 103
###begin article-title 104
muO-conotoxin MrVIB selectively blocks Nav1.8 sensory neuron specific sodium channels and chronic pain behavior without motor deficits
###end article-title 104
###begin article-title 105
###xml 123 127 <span type="species:ncbi:10116">rats</span>
Calcitonin gene-related peptide enhances TTX-resistant sodium currents in cultured dorsal root ganglion neurons from adult rats
###end article-title 105
###begin article-title 106
###xml 46 49 <span type="species:ncbi:10116">rat</span>
5HT increases excitability of nociceptor-like rat dorsal root ganglion neurons via cAMP-coupled TTX-resistant Na(+) channels
###end article-title 106
###begin article-title 107
###xml 63 66 <span type="species:ncbi:10116">rat</span>
Prostaglandin E2 potentiates a TTX-resistant sodium current in rat capsaicin-sensitive vagal pulmonary sensory neurones
###end article-title 107
###begin article-title 108
###xml 51 66 <span type="species:ncbi:10029">Chinese hamster</span>
Multiple mechanisms of arachidonic acid release in Chinese hamster ovary cells transfected with cDNA of substance P receptor
###end article-title 108
###begin article-title 109
Multiple intracellular signaling pathways of the neuropeptide substance P receptor
###end article-title 109
###begin article-title 110
###xml 139 154 <span type="species:ncbi:10029">Chinese hamster</span>
Direct linkage of three tachykinin receptors to stimulation of both phosphatidylinositol hydrolysis and cyclic AMP cascades in transfected Chinese hamster ovary cells
###end article-title 110
###begin article-title 111
###xml 86 101 <span type="species:ncbi:10029">Chinese hamster</span>
Ligand binding kinetics of substance P and neurokinin A receptors stably expressed in Chinese hamster ovary cells and evidence for differential stimulation of inositol 1,4,5-trisphosphate and cyclic AMP second messenger responses
###end article-title 111
###begin article-title 112
Effect of 8-bromo-cAMP on the tetrodotoxin-resistant sodium (Nav 1.8) current in small-diameter nodose ganglion neurons
###end article-title 112
###begin article-title 113
Differential modulation of TTX-sensitive and TTX-resistant Na+ channels in spinal cord astrocytes following activation of protein kinase C
###end article-title 113
###begin article-title 114
Changes in the expression of tetrodotoxin-sensitive sodium channels within dorsal root ganglia neurons in inflammatory pain
###end article-title 114
###begin article-title 115
###xml 128 131 <span type="species:ncbi:10116">rat</span>
Ibuprofen blocks changes in Na v 1.7 and 1.8 sodium channels associated with complete Freund's adjuvant-induced inflammation in rat
###end article-title 115
###begin article-title 116
SNS Na+ channel expression increases in dorsal root ganglion neurons in the carrageenan inflammatory pain model
###end article-title 116
###begin article-title 117
The role of Na(V)1.8 sodium channel in the maintenance of chronic inflammatory hypernociception
###end article-title 117

